Search Results
Feb 17, 2026, 08:26 ET Cooper Standard Announces Proposed Private Offering of $1.1 Billion of Senior Secured First Lien Notes
due 2031 (the "Notes") in a private offering. The Notes will be the senior secured obligations of, and will be guaranteed on a senior secured basis by, CS Intermediate HoldCo 1 LLC and certain of the Issuer's domestic subsidiaries that guarantee certain other indebtedness. The Notes will also be guaranteed
More news about: Cooper Standard
Feb 17, 2026, 07:00 ET Hint Health Releases New Benchmark Report Measuring the Patient Experience in Direct Primary Care
patient experienceThe PCPCM evaluates how care performs across the four core functions of primary care, known as the "4Cs": first contact, comprehensiveness, coordination, and continuity. The report is intended to provide DPC practices with a practical benchmark for measuring
More news about: Hint Health
Feb 17, 2026, 03:21 ET CS Analytical Expands Pharmaceutical Raw Material and Finished Product Testing with the Launch of RM Analytical
About CS Analytical LaboratoryThe only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world's leading experts
More news about: CS Analytical
Feb 16, 2026, 11:15 ET Hyundai America Technical Center and C.S. Mott Children's Hospital Partner to Promote Pedestrian, Bike and Car Seat Safety
multimedia:https://www.prnewswire.com/news-releases/hyundai-america-technical-center-and-cs-mott-childrens-hospital-partner-to-promote-pedestrian-bike-and-car-seat-safety-302688770.htmlSOURCE
More news about: Hyundai Motor America
Feb 15, 2026, 19:10 ET CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
optimization and expansion strategies. We are now actively advancing CS2009 clinical program globally and look forward to sharing further updates as the study progresses."About CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)CS2009, an innovative trispecific antibody designed and developed by
More news about: CStone Pharmaceuticals
Feb 12, 2026, 09:00 ET North Square Strategic Income Fund Winner of Active Fixed Income Mutual Fund of the Year at with.Intelligence Mutual Fund & ETF Awards 2026 Ceremony
management arm of Azimut Group in the U.S.: Azimut NSI, which is comprised of three 100% or majority-owned firms by Azimut Group: North Square Investments, CS McKee and Kennedy Capital Management. As of January 31, 2026, Azimut NSI had approximately $21.8 billion of assets under management. The Azimut Group
More news about: North Square Investments
Feb 11, 2026, 19:20 ET Fermi America Deepens Strategic Partnership with Hyundai E&C to Lead the Return of Large-Scale Nuclear Construction in the U.S. with Project Matador
Fermi America joined Hyundai E&C's Large-Scale Nuclear Technology Seminar in Dallas to engage contractors and strengthen U.S. nuclear supply chain and workforce readiness.Ongoing FEED work advances planning for four AP1000 units supporting Project Matador,
More news about: Fermi America
Feb 10, 2026, 13:00 ET Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
5.110% Senior Notes due 2034 075887CS6$550,000,000
More news about: BD (Becton, Dickinson and Company)
Feb 10, 2026, 07:23 ET XM Launches Promotion Offering Traders Up to $52,500 in Bonuses
support, and outstanding education. Risk Warning: Trading involves significant risks and may result in the loss of your invested capital. T&Cs apply Disclaimer: Promotions and bonuses are not available for accounts registered under XM's EU-based entity. Specific regions may
More news about: XM
Feb 10, 2026, 05:11 ET HiBy W4: Un DAC/AMP portátil que fusiona Hi-Fi inalámbrica y con cable
significativamente la experiencia del usuario.El rendimiento de audio es un aspecto fundamental y fiable de HiBy. HiBy W4 integra dos chips DAC Cirrus Logic CS43198, junto con dos amplificadores de auriculares, compatibles con PCM de hasta 768 kHz/32 bits y DSD512 nativo. Sus dos osciladores de cristal activos
More news about: HiBy
Feb 10, 2026, 05:09 ET HiBy W4: Ein tragbarer DAC/AMP, der kabellose und kabelgebundene HiFi-Geräte miteinander verbindet
Benutzererlebnis erheblich.Die Audioleistung ist ein zentraler und zuverlässiger Aspekt von HiBy. Der HiBy W4 integriert zwei Cirrus Logic DAC-Chips CS43198, gepaart mit zwei Kopfhörerverstärkern, die PCM bis zu 768 kHz/32 Bit und natives DSD512 unterstützen. Für eine präzise Audiowiedergabe sind zwei aktive
More news about: HiBy
Feb 10, 2026, 05:07 ET HiBy W4 : un DAC/AMP portable qui fusionne la hi-fi sans fil et la hi-fi filaire
l'expérience de l'utilisateur.La performance audio est un aspect essentiel et fiable sur HiBy. Le HiBy W4 intègre deux puces DAC Cirrus Logic CS43198, associées à deux amplificateurs de casque, prenant en charge le PCM jusqu'à 768 kHz/32 bits et le DSD512 en natif. Deux oscillateurs à cristal actif
More news about: HiBy
Feb 10, 2026, 05:05 ET HiBy W4: un DAC/AMP portátil que combina alta fidelidad inalámbrica y por cable
experiencia del usuario.El rendimiento del audio es un aspecto fundamental y confiable en HiBy. HiBy W4 integra dos chips DAC Cirrus Logic CS43198, combinados con dos amplificadores de auriculares, compatibles con PCM de hasta 768 kHz/32 bits y DSD512 nativo. Se han equipado dos osciladores de
More news about: HiBy
Feb 09, 2026, 13:15 ET National Organization for Rare Disorders Ranks All 50 States on Rare Disease Policies
states, Colorado, Delaware, Maine, and New Jersey, earned overall A grades, while most states clustered in the middle, with 25 earning Bs and 22 earning Cs, underscoring how widely protections still vary by geography."We applaud the progress over the past year," said Pamela K. Gavin, Chief Executive
More news about: National Organization for Rare Disorders (NORD®)
Feb 09, 2026, 09:00 ET Entering Fourth Year as Part of Global Sae-A Group, Ssangyong E&C Gains Momentum with Strong Backing of Global Sae-A
overseas orders increased more than eightfold, rising from USD 121 million in 2022 to USD 650 million in 2025. This sharp growth reflects Ssangyong E&C's restored standing as a recognized overseas contractor and its renewed global competitiveness.Following its integration into the Global Sae-A
More news about: Global Sae-A Group
Feb 09, 2026, 03:11 ET HiBy W4: A Portable DAC/AMP Merging Wireless & Wired HiFi
significantly enhances the user experience.Audio performance is a core and reliable aspect on HiBy. HiBy W4 integrates dual Cirrus Logic DAC chips CS43198, paired with dual headphone amplifiers, supporting PCM up to 768kHz/32-bit and native DSD512. Dual low-phase-noise active crystal oscillators at 45.1584MHz
More news about: HiBy
Feb 09, 2026, 02:48 ET HiBy W4: A Portable DAC/AMP Merging Wireless & Wired HiFi
experience.Audio performance is a core and reliable aspect on HiBy. HiBy W4 integrates dual Cirrus Logic DAC chips CS43198, paired with dual headphone amplifiers, supporting PCM up to 768kHz/32-bit and native DSD512. Dual low-phase-noise active crystal oscillators at 45.1584MHz
More news about: HiBy
Feb 09, 2026, 00:00 ET Ssangyong E&C Gains Momentum with Strong Backing of Global Sae-A
and established an Energy Business Team to expand into renewable energy projects.Supported by domestic and overseas project wins, Ssangyong E&C's order backlog increased by nearly 50%, rising from USD 4.7 billion in 2022 to USD 6.7 billion in 2025.Revenue is expected to increase from
More news about: Global Sae-A Group
Feb 06, 2026, 16:27 ET 2025's Top-Rated Software Solutions Identified Through Info-Tech Research Group's SoftwareReviews Platform
DocuSign (9.19 CS) enables fast, secure digital approvals and e-signatures that help teams complete agreements quickly from anywhere.
More news about: Info-Tech Research Group
Feb 05, 2026, 16:58 ET Top Business Intelligence & Analytics Providers Revealed in Info-Tech Research Group's 2026 Data Quadrant Report
to recommend, features scores, net emotional footprint score, and vendor capabilities. These dimensions are aggregated into a Composite Score (CS), which reflects overall user satisfaction and determines the product's placement within the Data Quadrant. The firm's methodology ensures that rankings
More news about: Info-Tech Research Group
Feb 04, 2026, 18:32 ET ITAÚ UNIBANCO - Fato Relevante: Projeções 2026
Alíquota efetiva de IR/CS Entre 29,5% e 32,5%
More news about: Itaú Unibanco Holding S.A.
Feb 04, 2026, 11:00 ET LG ENABLES DOLBY ATMOS FLEXCONNECT ON SELECT 2025 LG OLED TVS THROUGH SOFTWARE UPDATE
C5, and CS5 TVs via a software update, allowing customers to enjoy immersive Dolby Atmos even without a soundbar, and to expand their audio system over time.2025 OLED TV Software Update (G5, C5, and CS5) LG has released a software update for its 2025 OLED G5, C5, and CS5 TVs, enabling
More news about: LG Electronics USA
Feb 04, 2026, 09:00 ET Ultra I&C demonstrates data movement mastery with Hidden Level at WEST 2026
load. Ultra I&C's certified data dissemination will then deliver the right information to effector networks. Through machine learning, the critical intelligence delivered enables operators to quickly validate what matters."This powerful demonstration showcases Ultra I&C's mastery of moving
More news about: Ultra I&C
Feb 04, 2026, 04:38 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
Program enables patients that have completed the Phase IIa trial to gain access to CS1. CS014, a new chemical entity with disease-modifying potential, showed favorable safety and tolerability profile in a Phase I trial. CS014 is a HDAC inhibitor with a multimodal mechanism of action as an epigenetic modulator
More news about: Cereno Scientific
Feb 04, 2026, 04:29 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
Program enables patients that have completed the Phase IIa trial to gain access to CS1. CS014, a new chemical entity with disease-modifying potential, showed favorable safety and tolerability profile in a Phase I trial. CS014 is a HDAC inhibitor with a multimodal mechanism of action as an epigenetic modulator
More news about: Cereno Scientific